Cell Reports Medicine

Cell Reports Medicine

细胞医学报道

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Cell Reports Medicine》是由Elsevier出版社于2020年创办的英文国际期刊(ISSN: 2666-3791,E-ISSN: 2666-3791),该期刊长期致力于医学:研究与实验领域的创新研究,主要研究方向为Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA开放获取模式(OA占比%),以发表医学:研究与实验领域等方向的原创性研究为核心(研究类文章占比95.74%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在305篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cell Reports Medicine审稿周期约为约Time to desk decision: 6.6 days; Publication time: 3.31 weeks 17 Weeks 。该刊近年未被列入国际预警名单,年发文量约305篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 305 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 CELL BIOLOGY 细胞生物学
1区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 CELL BIOLOGY 细胞生物学
1区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CELL BIOLOGY SCIE Q1 22 / 205

89.5%

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 10 / 189

95%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CELL BIOLOGY SCIE Q1 14 / 205

93.41%

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 8 / 189

96.03%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:15 SJR:4.276 SNIP:1.664
学科类别 分区 排名 百分位
大类:Medicine 小类:General Medicine Q1 25 / 636

96%

大类:Medicine 小类:General Biochemistry, Genetics and Molecular Biology Q1 18 / 221

92%

期刊发文

  • Current understanding of the intratumoral microbiome in various tumors

    Author: Xue, Chen; Chu, Qingfei; Zheng, Qiuxian; Yuan, Xin; Su, Yuanshuai; Bao, Zhengyi; Lu, Juan; Li, Lanjuan

    Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100884

  • Inherited mutations in Chinese patients with upper tract urothelial carcinoma

    Author: Wu, Junlong; Jin, Shengming; Gu, Chengyuan; Wei, Yu; Zhu, Yao; Necchi, Andrea; Shariat, Shahrokh F.; Pan, Jian; Gan, Hualei; Dai, Bo; Zhang, Hailiang; Shi, Guohai; Zhu, Yu; Shen, Yijun; Zhu, Yiping; Ye, Dingwei

    Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100883

  • Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases

    Author: Guo, Jiawei; Wang, Fuxiao; Hu, Yan; Luo, Ying; Wei, Yan; Xu, Ke; Zhang, Hao; Liu, Han; Bo, Lumin; Lv, Shunli; Sheng, Shihao; Zhuang, Xinchen; Zhang, Tao; Xu, Can; Chen, Xiao; Su, Jiacan

    Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100881

  • Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET

    Author: Zhang, Qilin; Yao, Boyuan; Long, Xin; Chen, Zhengyuan; He, Min; Wu, Yue; Qiao, Nidan; Ma, Zengyi; Ye, Zhao; Zhang, Yichao; Yao, Shun; Wang, Ye; Cheng, Haixia; Chen, Hong; Ye, Hongying; Wang, Yongfei; Li, Yimin; Chen, Jianhua; Zhang, Zhaoyun; Guo, Fan; Zhao, Yao

    Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2023.100934

  • Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study

    Author: Wang, Han-Min; Zhang, Chan-Yuan; Peng, Kai-Cheng; Chen, Ze-Xin; Su, Jun-Wei; Li, Yu-Fa; Li, Wen-Feng; Gao, Qing-Yun; Zhang, Shi-Ling; Chen, Yu-Qing; Zhou, Qing; Xu, Cong; Xu, Chong-Rui; Wang, Zhen; Su, Jian; Yan, Hong-Hong; Zhang, Xu-Chao; Chen, Hua-Jun; Wu, Yi-Long; Yang, Jin-Ji

    Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100911

  • Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma

    Author: Tian, Xiao-Peng; Zhang, Yu-Chen; Lin, Ning-Jing; Wang, Liang; Li, Zhi-Hua; Guo, Han-Guo; Ma, Shu-Yun; An, Ming-Jie; Yang, Jing; Hong, Yu-Heng; Wang, Xian-Huo; Zhou, Hui; Li, Ya-Jun; Rao, Hui-Lan; Li, Mei; Hu, Shao-Xuan; Lin, Tong-Yu; Li, Zhi-Ming; Huang, He; Liang, Yang; Xia, Zhong-Jun; Lv, Yue; Liu, Yu-Ying; Duan, Zhao-Hui; Chen, Qing-Yu; Wang, Jin-Ni; Cai, Jun; Xie, Ying; Ong, Choon-Kiat; Liu, Fang; Liu, Yan-yan; Yan, Zheng; Huang, Liang; Tao, Rong; Li, Wen-Yu; Huang, Hui-Qiang; Cai, Qing-Qing

    Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100859

  • Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer

    Author: Tang, Zhaoqing; Gu, Yuan; Shi, Zhongyi; Min, Lingqiang; Zhang, Ziwei; Zhou, Peng; Luo, Rongkui; Wang, Yan; Cui, Yuehong; Sun, Yihong; Wang, Xuefei

    Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2023.100931

  • DeepFundus: A flow-cytometry-like image quality classifier for boosting the whole life cycle of medical artificial intelligence

    Author: Liu, Lixue; Wu, Xiaohang; Lin, Duoru; Zhao, Lanqin; Li, Mingyuan; Yun, Dongyuan; Lin, Zhenzhe; Pang, Jianyu; Li, Longhui; Wu, Yuxuan; Lai, Weiyi; Xiao, Wei; Shang, Yuanjun; Feng, Weibo; Tan, Xiao; Li, Qiang; Liu, Shenzhen; Lin, Xinxin; Sun, Jiaxin; Zhao, Yiqi; Yang, Ximei; Ye, Qinying; Zhong, Yuesi; Huang, Xi; He, Yuan; Fu, Ziwei; Xiang, Yi; Zhang, Li; Zhao, Mingwei; Qu, Jinfeng; Xu, Fan; Lu, Peng; Li, Jianqiao; Xu, Fabao; Wei, Wenbin; Dong, Li; Dai, Guangzheng; He, Xingru; Yan, Wentao; Zhu, Qiaolin; Lu, Linna; Zhang, Jiaying; Zhou, Wei; Meng, Xiangda; Li, Shiying; Shen, Mei; Jiang, Qin; Chen, Nan; Zhou, Xingtao; Li, Meiyan; Wang, Yan; Zou, Haohan; Zhong, Hua; Yang, Wenyan; Shou, Wulin; Zhong, Xingwu; Yang, Zhenduo; Ding, Lin; Hu, Yongcheng; Tan, Gang; He, Wanji; Zhao, Xin; Chen, Yuzhong; Liu, Yizhi; Lin, Haotian

    Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100912